Literature DB >> 2136894

Requirements for the adoptive transfer of antibody responses to a priming antigen in man.

J Z Wimperis1, D Gottlieb, A S Duncombe, H E Heslop, H G Prentice, M K Brenner.   

Abstract

Antibody responses to recall vaccines can be adoptively transferred after marrow transplantation in man. Transfer of responses to priming Ag has not been successful, although this would broaden the range of organisms to which recipients could be protected. To investigate the importance of T cells and Ag in such transfer we primed marrow donors with keyhole limpet hemocyanin (KLH) 1 or 3 wk before marrow harvesting. B cells secreting IgM and IgG anti-KLH antibody were present in donor marrow at both 1 and 3 wk after immunization. After T cell depletion, donor marrow was infused into chemo-irradiated recipients, half of whom were immunized pretransplant with KLH. We found no evidence for the transfer of the IgM component of the response. Clonal expansion of the transferred IgG antibody-secreting cells with a corresponding rise in recipient serum IgG antibody levels was seen only when donors were primed 3 wk before marrow harvest and when the recipients were also immunized. IEF and immunoblotting demonstrated that successful transfer coincided with maturation of the IgG primary response from a polyclonal to an oligoclonal pattern and confirmed that donor oligoclonal bands appeared in the recipient serum. We conclude that the immunization protocols required for the transfer of antibody responses to priming Ag reflect the initial dependence of unprimed B cells on T cell help and on prolonged Ag stimulation. Ag-stimulated primary B cells in T cell-depleted marrow respond only to the noncognate growth and differentiation signals available in the chemo-irradiated recipient after an initial period of clonal selection and expansion in the donor which is both T cell and Ag dependent. Even after this initial selection, continued expansion of antibody-secreting clones in recipients retains an absolute dependence on Ag stimulation. Immunization techniques to protect transplant recipients against organisms such as Pseudomonas and CMV may need to be modified accordingly.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2136894

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Risk factors for viral reactivation following bone marrow transplantation.

Authors:  D Pillay; A Webster; H G Prentice; P D Griffiths
Journal:  Ann Hematol       Date:  1992-06       Impact factor: 3.673

Review 2.  Gene-modified cells for stem cell transplantation and cancer therapy.

Authors:  Malcolm K Brenner
Journal:  Hum Gene Ther       Date:  2014-07       Impact factor: 5.695

3.  Effect of donor and recipient immunization protocols on primary and secondary human antibody responses in SCID mice reconstituted with human peripheral blood mononuclear cells.

Authors:  R B Markham; A D Donnenberg
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

Review 4.  Translational Mini-Review Series on B cell subsets in disease. Reconstitution after haematopoietic stem cell transplantation - revelation of B cell developmental pathways and lineage phenotypes.

Authors:  M Bemark; J Holmqvist; J Abrahamsson; K Mellgren
Journal:  Clin Exp Immunol       Date:  2012-01       Impact factor: 4.330

Review 5.  B cells and transplantation: an educational resource.

Authors:  Trudy N Small; William H Robinson; David B Miklos
Journal:  Biol Blood Marrow Transplant       Date:  2009-01       Impact factor: 5.742

6.  IL-2 infusion abrogates humoral immune responses in humans.

Authors:  D J Gottlieb; H G Prentice; H E Heslop; C Bello; M K Brenner
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330

7.  Development of antibodies to hepatitis B virus surface antigen in bone marrow transplant recipient following treatment with peripheral blood lymphocytes from immunized donors.

Authors:  Y Ilan; A Nagler; D Shouval; A Ackerstein; R Or; J Kapelushnik; R Adler; S Slavin
Journal:  Clin Exp Immunol       Date:  1994-08       Impact factor: 4.330

Review 8.  Reconstitution of the immune system after hematopoietic stem cell transplantation in humans.

Authors:  Jan Storek; Michelle Geddes; Faisal Khan; Bertrand Huard; Claudine Helg; Yves Chalandon; Jakob Passweg; Eddy Roosnek
Journal:  Semin Immunopathol       Date:  2008-10-24       Impact factor: 9.623

9.  Resetting the adaptive immune system after autologous stem cell transplantation: lessons from responses to vaccines.

Authors:  D M C Brinkman; C M Jol-van der Zijde; M M ten Dam; P A W te Boekhorst; R ten Cate; N M Wulffraat; R Q Hintzen; J M Vossen; M J D van Tol
Journal:  J Clin Immunol       Date:  2007-08-10       Impact factor: 8.317

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.